From the Food and Drug Administration.
Office of Health Affairs, Rockville, MD 20857.
S L
SL
Nightingale
D000437:Alcoholism / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017277:Drug Approval; D004797:Enzyme-Linked Immunosorbent Assay; D015483:HIV Antibodies / Q000032:analysis*; D015658:HIV Infections / Q000175:diagnosis* / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D008687:Metformin / Q000627:therapeutic use*; D009271:Naltrexone / Q000627:therapeutic use*; D012463:Saliva / Q000276:immunology / Q000821:virology*; D014481:United States; D014486:United States Food and Drug Administration
D015483:HIV Antibodies; D009271:Naltrexone; D008687:Metformin